Cosciens Biopharma Inc
(CSCIF)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2019 | 03-2019 | 12-2018 | 09-2018 | 06-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,705 | -4,911 | 4,187 | N/A | 11,822 |
| Depreciation Amortization | 100 | 48 | -551 | N/A | -506 |
| Income taxes - deferred | N/A | N/A | 3,479 | N/A | 3,479 |
| Accounts receivable | -196 | -329 | -95 | N/A | -269 |
| Other Working Capital | -785 | -874 | -151 | N/A | -533 |
| Other Operating Activity | 410 | 3,060 | -44 | 0 | -2,053 |
| Operating Cash Flow | $-5,176 | $-3,006 | $6,825 | $N/A | $11,940 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | 15 | N/A | 11 |
| Other Investing Activity | 50 | 50 | -50 | 0 | 0 |
| Investing Cash Flow | $50 | $50 | $-35 | $N/A | $11 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 314 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -310 | -151 | 0 | 0 | 0 |
| Financing Cash Flow | $4 | $-151 | $N/A | $N/A | $N/A |
| Exchange Rate Effect | 293 | -48 | -58 | N/A | 215 |
| Beginning Cash Position | 14,512 | 14,512 | 7,780 | N/A | 7,780 |
| End Cash Position | 9,683 | 11,357 | 14,512 | N/A | 19,946 |
| Net Cash Flow | $-4,829 | $-3,155 | $6,732 | $N/A | $12,166 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,176 | -3,006 | 6,825 | N/A | 11,940 |
| Capital Expenditure | N/A | N/A | -9 | N/A | N/A |
| Free Cash Flow | -5,176 | -3,006 | 6,816 | 0 | 11,940 |